The global clinical laboratory tests market was valued at USD 145.66 billion in 2025 and is projected to grow from USD 155.11 billion in 2026 to USD 256.52 billion by 2034 , registering a CAGR of 6.49% during 2026-2034 . North America dominated the market with a 42.5% share in 2025 , while Asia Pacific is expected to register the fastest CAGR of 8.3% during the forecast period.
Market Size...
The global anti-hiv drugs market is witnessing steady growth as healthcare systems continue to expand access to antiretroviral therapy, improve HIV diagnosis and treatment programs, and strengthen long-term disease management. Anti-HIV drugs include multiple classes of antiretroviral medicines used in combination therapies to suppress HIV replication, maintain immune function, and reduce the...
The global Molecular Diagnostics Market is projected to grow from USD 19.4 billion in 2026 to USD 25.6 billion by 2033, registering a 4.1% CAGR. The market reached USD 18.8 billion in 2025, with North America accounting for the largest regional share at 44.1%.
The industry's growth reflects increasing demand for precise diagnostics, technological advancement,...
Infectious Disease Testing Market
The Infectious Disease Testing Market is experiencing strong expansion driven by the rising global burden of infectious diseases, increasing demand for early diagnosis, and advancements in molecular diagnostic technologies. The market size was valued at USD 28 billion in 2025 and is projected to grow from USD 30 billion in 2026 to USD...
Influenza Treatment Market
The global Influenza Treatment Market is witnessing steady growth due to the rising prevalence of seasonal influenza infections, increasing awareness regarding early diagnosis and treatment, and continuous advancements in antiviral therapeutics. The market size was valued at USD 6.8 billion in 2025 and is projected to grow from USD 7 billion in 2026 to USD 12 billion...
The global anti-viral coatings market is witnessing strong expansion, supported by increasing awareness of hygiene, infection control, and surface protection across healthcare, public infrastructure, and consumer applications. Valued at USD 0.58 billion in 2025, the market is projected to reach USD 0.65 billion in 2026 and further expand to USD 1.75 billion by 2034, registering a...
The global infectious disease testing market is experiencing significant growth due to the increasing prevalence of infectious diseases, rising awareness regarding early disease diagnosis, and growing adoption of advanced diagnostic technologies. Infectious disease testing plays a critical role in detecting bacterial, viral, fungal, and parasitic infections, enabling timely treatment...
The recent ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda has once again raised global concerns about infectious diseases and public health preparedness. Health authorities, governments, and international organizations are working tirelessly to contain the spread of the disease and protect vulnerable communities. The return of Ebola serves as a...
The hepatitis B therapeutics market size was valued at USD 2.48 billion in 2025 and is projected to grow from USD 2.76 billion in 2026 to USD 7.54 billion by 2034 at a CAGR of 11.85% during the forecast period (2026-2034), as per Straits Research analysis.
Key Highlights
North America dominated the global hepatitis B therapeutics market.
Asia-Pacific is expected to be the...
Respiratory health has become an increasingly important focus within global healthcare systems, particularly with the rising prevalence of chronic respiratory conditions. Devices that enable efficient drug delivery directly to the lungs are gaining attention, and nebulizers remain a key component in this space. These medical devices convert liquid medication into a fine mist, allowing...
The Anti-Infective Drugs Market continues to play a foundational role in global healthcare systems, addressing a broad spectrum of bacterial, viral, fungal, and parasitic infections. Valued at US$ 134,267.21 Million in 2024, the market is projected to expand at a CAGR of 3.1% from 2025 to 2032. Despite moderate growth, sustained demand is supported by rising infectious disease prevalence,...
The Respiratory Disease Testing Market continues to play a critical role in global healthcare as respiratory conditions remain among the leading causes of morbidity and mortality worldwide. Valued at USD 6,590.43 million in 2024, the market is projected to grow at a CAGR of 2.99% from 2025 to 2032. The steady expansion is driven by increasing prevalence of chronic respiratory diseases, rising...